{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T04:15:22Z","timestamp":1742703322441,"version":"3.40.2"},"reference-count":18,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2012]]},"DOI":"10.1536\/ihj.53.72","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T21:33:07Z","timestamp":1330983187000},"page":"72-74","source":"Crossref","is-referenced-by-count":2,"title":["Preliminary Report of Tolvaptan Treatment in Japanese Patients With Heart Failure"],"prefix":"10.1536","volume":"53","author":[{"given":"Hiroaki","family":"Semba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Inajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriko","family":"Hasumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Yonenaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.08.005"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(02)00823-0"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.2008.04.01.103"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shiba N, Watanabe J, Shinozaki T, <i>et al<\/i>. Analysis of chronic heart failure registry in the Tohoku district: third year follow-up. Circ J 2004; 68: 427-34.","DOI":"10.1253\/circj.68.427"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010641"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.110933"},{"key":"7","unstructured":"7. Guidelines for Treatment of Acute Heart Failure (JCS 2006)."},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000057794.29667.08"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.03.019"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ikram H, Chan W, Espiner ER, Nicholls MG. Haemodynamic and hormone responses to acute and chronic frusemide therapy in congestive heart failure. Clin Sci (Lond) 1980; 59: 443-9.","DOI":"10.1042\/cs0590443"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908193410806"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00765-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol 2006; 97: 1759-64.","DOI":"10.1016\/j.amjcard.2005.12.072"},{"issue":"9 Supplement 1","key":"14","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1016\/j.cardfail.2010.07.147","volume":"16","author":"WATANABE RYO","year":"2010","ISSN":"https:\/\/id.crossref.org\/issn\/1071-9164","issn-type":"print"},{"key":"15","unstructured":"15. Matsuzaki M, <i>et al<\/i>. Clinical effect of tolvaptan, an oral vasopressin V2 receptor antagonist, in patients with chronic heart failure and peripheral edema. Results from a double-blind, randomized trial. Circ J 2009; 73: 127."},{"issue":"3","key":"16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","volume":"287","author":"YAMAMURA Y","year":"1998","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.12.1319"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.16.1963"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T12:18:40Z","timestamp":1742645920000},"score":1,"resource":{"primary":{"URL":"http:\/\/joi.jlc.jst.go.jp\/JST.JSTAGE\/ihj\/53.72?from=CrossRef"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.53.72","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"type":"print","value":"1349-2365"},{"type":"electronic","value":"1349-3299"}],"subject":[],"published":{"date-parts":[[2012]]}}}